Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metact® Combination Tablets Special Drug Use Surveillance Survey on Long-term Use for Type 2 Diabetes Mellitus

NCT02024971 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02024971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02024971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metact® Combination Tablets Special Drug Use Surveillance Survey on Long-term Use for Type 2 Diabetes Mellitus
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
July 31, 2010
Completion date
November 30, 2013
Enrollment
1,103 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus